Abstract
Background
Peripheral cholangiocarcinoma (CCC) is less common than hepatocellular carcinoma. Little is known about CCC patients older than 70 years who have undergone hepatectomy.
Methods
Between 1977 and 2004, the clinical features of 33 elderly CCC patients (>70 years old) undergoing hepatectomy were reviewed, and 185 CCC patients younger than 70 years (younger CCC) were used for comparison.
Results
A total of 218 CCC patients undergoing hepatectomy were investigated with ages ranging from 28 to 93 years (median, 59.0 years). The elderly and younger CCC groups had a similar sex ratio and a similar positive rate of carcinoembryonic antigen (CEA) and CA19-9. A similar rate of hepatolithiasis, mucobilia, papillary pattern, stage distribution, curative hepatectomy, surgical morbidity, and mortality for CCC were also observed between the two groups. During a follow-up duration ranging from 1.1 to 145.0 months (median, 11.7 months), elderly CCC and younger CCC patients had similar prognoses after hepatectomy (P = .827). Elderly CCC patients with a low CEA level, an intraductal papillary growth pattern, curative hepatectomy, and postoperative chemotherapy tended to have favorable survival. However, elderly CCC patients with a low CEA level independently showed favorable survival.
Conclusions
Hepatectomy is feasible for selected elderly CCC patients. Elderly CCC patients undergoing hepatectomy had clinicopathologic features and prognoses similar to those of patients younger than 70 years undergoing hepatectomy. Elderly CCC patients with a low CEA level, intraductal papillary growth pattern, curative hepatectomy, and postoperative chemotherapy tended to have favorable survival. However, elderly CCC patients with low CEA level independently showed favorable survival.
Similar content being viewed by others
References
Chen MF. Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 1999; 14:1144–9
Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. Tokyo: Kanehara, 1997
Suzuki H, Isaji S, Pairojkul C, Uttaravichien T. Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan. J Hepatobiliary Pancreat Surg 2000; 7:206–11
Sirica AE, Gainey TW, Harrell MB, Caran N. Cholangiocarcinogenesis and biliary adaptation responses in hepatic injury. In: Sirica AE, Longnecker DS, eds. Biliary and Pancreatic Ductal Epithelia—Pathobiology and Pathophysiology. New York: Marcel Dekker, 1997; 229–90
Wang J, Grossman B. Bladder carcinoma in patients age 40 years or younger. Cancer 1989; 64:178–81
Bloss RSD, Miller TA, Copeland EM. Carcinoma of the stomach in the young adult. Surg Gynecol Obstet 1980; 150:883–6
Recalde M, Holyoke ED, Elias EG. Carcinoma of the colon, rectum, and anal canal in young patients. Surg Gynecol Obstet 1974; 139:909–13
Monte SM, Mutchins GM, Moore GW. Influence of age on the metastatic behavior of breast carcinoma. Hum Pathol 1988; 19:529–34
Yeh CN, Jan YY, Chen MF. Influence of age on surgical treatment of peripheral cholangiocarcinoma. Am J Surg 2004; 187:559–63
Poon RTP, Fan ST, Lo CM, et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999; 94:2460–6
Yeh CN, Lee WC, Jeng LB, Chen MF. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology 2004; 51:219–23
Healy JE, Schroy PC. Anatomy of the biliary ducts within the human liver: analysis of the prevailing pattern of branching and the major variations of the biliary ducts. Arch Surg 1953; 66:599–616
Couinaud C. Le Foie: Etudes Anatomiques et Chirurgicales. Paris: Masson Publishers, 1957:187–208
Ponsioen CIJ, Tytgat GNJ. Primary sclerosing cholangitis: a clinical review. Am J Gastroenterol 1998; 93:515–23
Harrison PM. Prevention of bile duct cancer in primary sclerosing cholangitis. Ann Oncol 1999; 10(Suppl 4):S208–11
Komi N, Tamura T, Miyoshi Y. Histochemical and immunohistochemical studies on development of biliary carcinoma in forty-seven patients with choledochal cysts—special reference to intestinal metaplasia in the biliary duct. Jpn J Surg 1985; 15:273–8
Imazu M, Iwai N, Tokiwa K, et al. Factors of biliary carcinogenesis in choledochal cysts. Eur J Pediatr Surg 2001; 11:24–7
Weber SM, Jarnagin WR, Klimstra D. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193:384–91
Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33:1353–7
Shirabe K, Shimada M, Harimoto N. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 2002; 131:S159–64
Chen TC, Nakanuma Y, Zen Y, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 2001; 34:651–8
Cattel RB, Brausch JW, Kahn F. Polypoid epithelial tumors of the bile duct. N Engl J Med 1962; 226:57–61
Suh KS, Roh HR, Koh YT, et al. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 2000; 31:12–7
Buskirk S, Gunderson L, Adson M, et al. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1984; 10:2013–23
Yeh CN, Jan YY, Yeh TS, et al. Hepatic resection of intraductal papillary type of cholangiocarcinoma. Ann Surg Oncol 2004; 11:606–11
Kokudo N, Makuuchi M. Extent of resection and outcome after curative resection for intrahepatic cholangiocarcinoma. Surg Oncol Clin North Am 2002; 11:969–83
Jan YY, Yeh CN, Yeh TS, Hwang TL, Chen MF. Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg 2005; 29:894–8
Cantore M, Rabbi C, Guadagni S, et al. Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. Ann Oncol 2002; 13:1687–8
Heyna M, Pruckmayer M, Radere M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 1998; 34:977–86
Ellis PA, Norman A, Hill A, et al. Epirubicin, cisplatin and infusional 5-fluorouracil (ECF) in hepatobiliary tumours. Eur J Cancer 1995; 31:1594–8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeh, CN., Jan, YY. & Chen, MF. Hepatectomy for Peripheral Cholangiocarcinoma in Elderly Patients. Ann Surg Oncol 13, 1553–1559 (2006). https://doi.org/10.1245/s10434-006-9085-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-006-9085-x